Filing Details
- Accession Number:
- 0001181431-13-059343
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2013-11-15 20:55:26
- Reporting Period:
- 2013-11-13
- Filing Date:
- 2013-11-15
- Accepted Time:
- 2013-11-15 20:55:26
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1497253 | Organovo Holdings Inc. | ONVO | Biological Products, (No Disgnostic Substances) (2836) | 271488943 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1549671 | Eric David | 6275 Nancy Ridge Drive, Suite 110 San Diego CA 92121 | Chief Strategy Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Disposition | 2013-11-13 | 16,470 | $10.39 | 731,306 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Direct |
Footnotes
- These shares were acquired pursuant to a cashless exercise of an in-the-money warrant exempt from Section 16(b). The Reporting Person initially acquired the warrant on February 8, 2012.
- This transaction was executed in multiple sales through a sale order executed by a broker-dealer at prices ranging from $10.30 to $10.45. The price reported in this column reflects the weighted average sale price. The Reporting Person will provide upon request to the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price.
- This number does not include 700,000 shares of common stock underlying outstanding options held by Mr. David; post-transaction Mr. David continues to beneficially own or have a right to acquire 1,431,306 shares of common stock.